Health Care

Novel leukemia treatment could be 1st US gene therapy

Cancer experts who advise government regulators are reviewing what could be the first gene therapy approved in the U.S. The Food and Drug Administration panel is holding a hearing Wednesday to discuss the treatment developed by the University of Pennsylvania and Novartis Corp.

The price dilemma over a $16,000 drug

Novartis AG recently discovered that a drug it sells for a group of very rare diseases could be used to treat a much more common ailment. There is just one problem: its $16,000-per-dose price tag.

Charlie Gard: Treatment can prolong life, Dr. Marc Siegel says

The parents of Charlie Gard, an 11-month old terminally ill baby in Britain, want to take their child to America to get treatment for a rare disease which has caused brain damage. But socialized medicine in Britain put the government in charge of the child’s life.

ObamaCare coverage gains eroding, new survey indicates

As Republicans struggle to coalesce around a plan to repeal and replace the Affordable Care Act, 2 million more adults are without health insurance this year, according to a new survey, putting added pressure on lawmakers to fix the nation’s health care system.